Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Immunoconjugates (BR96-DOX) were prepared between chimeric monoclonal antibody BR96 and the anticancer drug doxorubicin. The monoclonal antibody binds an antigen related to Lewi...